MedPath

AshLi Aerosol eliminator device - Comparing the advantages of a modified version to the previous one.

Phase 1
Conditions
Health Condition 1: J22- Unspecified acute lower respiratory infection
Registration Number
CTRI/2024/05/067415
Lead Sponsor
Asish K
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All the adult patients undergoing emergency and elective surgery under regional anaesthesia, at COVID operation theatre, where Ash Li aerosol eliminator is used

2.Patients who give consent to be part of the study

Exclusion Criteria

1.Patients undergoing surgery under General anesthesia

2.Patients with altered mentation

3.Patient who cannot cooperate with the study

4.Surgeries of more than 3 hours duration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reduced environmental contamination <br/ ><br>2. Better patient and physician acceptanceTimepoint: intraoperative period and immediate postoperative( within 1 hour after surgery)
Secondary Outcome Measures
NameTimeMethod
To compare the physician’s & patient’s acceptability among the two devices.Timepoint: 1
© Copyright 2025. All Rights Reserved by MedPath